Comparative Analysis of Silastic Stenting in Sinus Surgery

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19-89
SponsorUniversity of British Columbia

About this trial

Silastic stenting is a measure taken to support tissue healing following sinus surgery. Silastic stents are inserted into the sinus cavities and provide structural support while facilitating healing in the critical period of recovery following surgery. There is controversy over the optimal duration for which silastic stents should be left in place. Having them in place for shorter periods may reduce the likelihood of stent-related reactions, while leaving them for longer periods could promote more tissue healing. The aim of this study is to compare the impact of stent duration on clinical outcomes of patients following sinus surgery.

Eligibility criteria

Qualifiers

Patients diagnosed with chronic rhinosinusitis requiring Frontal drill-out.

Disqualifiers

Patients unwilling or unable to comply with the study protocol.

Previous Radiotherapy to operated area.

Trial design

Treatments tested in this trial

  • Silastic Stenting

Treatment groups

100 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

University of British Columbia

Lead sponsor

Addenbrooke's Hospital, Cambridge University

Collaborator

NHS Greater Glasgow and Clyde

Collaborator